2024 年至 2031 年直接面向消费者的基因检测市场（按检测类型、技术、最终用户和地区划分）

2024 年至 2031 年直接面向消费者的基因检测市场估值

直接面向消费者（DTC）的基因检测市场正在快速成长。人们对个人化医疗保健和保健的兴趣日益浓厚。消费者对自己的健康越来越积极主动，而DTC测试可以提供有关一个人独特基因组成的资讯。这些知识可以帮助人们根据其独特的生物学特性制定有关营养、运动甚至疾病预防的明智决定。预计各种组织将推动市场规模，预计到 2024 年将超过 14.3 亿美元，到 2031 年估值达到约 38.6 亿美元。

此外，人们对遗传疾病的认识不断提高以及对预防措施的重视也推动了 DTC 检测的需求。对具有成本效益且高效的直接面向消费者 (DTC) 基因检测的需求不断增长，推动市场在 2024 年至 2031 年期间的复合年增长率达到 13.25%。

直接面向消费者的基因检测市场：定义与概述

直接面向消费者（DTC）基因测试是指直接销售给消费者的测试，无需医疗保健专业人员的参与。这些测试通常评估一个人的 DNA，以确定祖先、遗传特征、某些疾病的遗传易感性，以及在某些情况下的治疗反应。提供 DTC 基因测试的公司通常会向消费者提供试剂盒，然后消费者收集 DNA 样本（通常是唾液）并将其送回公司进行分析。结果通常可以在线或透过行动应用程式获得，并且通常包括解释和建议。

DTC 基因检测由于其简单性以及它可能提供有关个人健康和遗传的洞察力而越来越受欢迎。消费者对自己患有阿兹海默症、癌症和心臟病等疾病的遗传易感性感到好奇，这些疾病可能会影响他们的生活方式选择并推动积极的医疗保健决策。另一个流行的应用是祖先测试，它可以让人们更多地瞭解他们的遗传遗产并与远亲建立联繫。

全基因组定序成本的降低等技术进步可能会提高这些测试所提供的资讯的准确性和范围。与电子病历和私人执业医生的整合可能会改善临床实践中对遗传数据的解释和使用。然而，人们仍然担心解释的准确性、基因数据的隐私以及直接获取敏感健康资讯可能造成的心理影响。DTC 基因检测的监管和监督可能会不断发展，以解决这些问题，同时保持消费者获取有用基因发现的管道。

日益增强的消费者意识如何推动直接面向消费者的基因检测市场的发展？

提高消费者知识是直接面向消费者（DTC）基因检测市场的主要驱动力。随着越来越多的人意识到瞭解自己的健康风险、优化治疗方案和做出明智的生活方式选择的潜在益处，对基因检测服务的需求预计会增加。宣传活动、教育活动和媒体报告对于让大众瞭解直接面向消费者的 DNA 检测 (DTC) 的可用性、价格和可及性至关重要。认知度的提高不仅会透过吸引新客户扩大市场，还会激励现有用户探索其他遗传见解，例如家谱和量身定制的健康计划。

根据美国国家医学图书馆的资料，直接面向消费者（DTC）的基因测试通常透过网路直接出售给消费者，无需医疗保健专业人员的参与。此次试验引起了正面和负面的关注。2008 年，《时代》杂誌将 23andMe 的 DTC 全基因组扫瞄评为 "年度创新" 。DTC 基因检测网站通常连结到科学研究，并可能包括用户论坛等互动功能。2012年，一次典型的测试花费数百美元。2011 年，23andMe 报告其销售了 10 万份全基因组扫瞄数据。

随着个人化医疗保健和健康的趋势日益增长以及重点转向个人化医疗保健和健康，对 DTC 基因检测的需求也日益增长。消费者越来越有兴趣瞭解自己的基因组成，以便做出更明智的生活方式、疾病预防和治疗决定。个人可以从 DTC 基因检测中受益，因为它提供了有关一个人独特基因特征的重要信息，使他们能够采取更加个性化的方法来治疗自己的健康。

法规和道德问题会影响直接面向消费者的基因检测市场的成长吗？

直接面向消费者（DTC）基因检测市场的监管和道德考量可能会对其扩张产生重大影响。监管课题，例如对基因测试结果的准确性、解释和报告的不同要求，可能会阻碍市场进入和扩张。对隐私保护和基因资料安全储存的不确定性增加了消费者的不信任和监管担忧。

关于基因资讯的适当使用和解释的伦理问题、对消费者的潜在心理影响以及对基因歧视的担忧都使市场动态变得复杂。透过透明的方式、强有力的资料保护措施和有效的监管框架解决这些问题将有助于建立客户信任并确保 DTC 基因检测市场的长期成功。

共享 DNA 引发了道德和隐私问题。消费者担心DTC公司会非法取得资料、洩漏资料或滥用他们的基因讯息，阻碍市场成长。成本和报销问题 DTC 测试费用昂贵，保险覆盖范围可能有限。对于许多潜在客户来说，这可能会成为进入的障碍。

目录

第 1 章 简介

• 市场定义
• 市场细分
• 调查方法

第 2 章执行摘要

• 主要发现
• 市场概况
• 市集亮点

第3章市场概况

• 市场规模和成长潜力
• 市场趋势
• 市场驱动力
• 市场制约因素
• 市场机会
• 波特五力分析

4. DTC 基因检测市场依检测类型划分

• 携带者检测
• 预测测试
• 家庭和谱系测试
• 营养基因组学测试

第5章 DTC 基因检测市场（依技术）

• 目标分析
• 单核甘酸多态性（SNP）晶片
• 全基因组定序（WGS）

第6章 区域分析

• 北美
• 美国
• 加拿大
• 墨西哥
• 欧洲
• 英国
• 德国
• 法国
• 义大利
• 亚太地区
• 中国
• 日本
• 印度
• 澳洲
• 拉丁美洲
• 巴西
• 阿根廷
• 智利
• 中东/非洲
• 南非
• 沙乌地阿拉伯
• 阿拉伯联合酋长国

第7章 市场动态

• 市场驱动力
• 市场制约因素
• 市场机会
• COVID-19 的市场影响

第8章 竞争格局

• 大公司
• 市场占有率分析

第9章 公司简介

• 23andMe
• Ancestry
• Color Genomics
• Helix
• Living DNA
• EasyDNA
• Full Genome Corporation
• Genesis Healthcare
• Family Tree DNA（Gene By Gene）
• MyHeritage

第10章市场前景与机遇

• 新兴技术
• 未来市场趋势
• 投资机会

第11章 附录

• 缩写表
• 来源和参考文献

Direct-To-Consumer (DTC) Genetic Testing Market Valuation - 2024-2031

The market for direct-to-consumer (DTC) genetic testing is growing rapidly. There is an increasing interest in individualized healthcare and wellness. Consumers are becoming more proactive about their health, and DTC testing provides information about their unique genetic composition. This knowledge can help people make informed decisions regarding nutrition, exercise, and even disease-preventive techniques, adapting their approach to their particular biology. The various organizations is driving the market size to surpass USD 1.43 Billion in 2024 to reach a valuation of aroundUSD 3.86 Billion by 2031.

Furthermore, rising awareness of genetic disorders and a focus on preventative measures are driving demand for DTC testing. The rising demand for cost-effective and efficient direct-to-consumer (DTC) genetic testing is enabling the market grow at aCAGR of 13.25% from 2024 to 2031.

Direct-To-Consumer (DTC) Genetic Testing Market: Definition/ Overview

Direct-to-consumer (DTC) genetic testing refers to tests that are sold directly to consumers without the involvement of healthcare experts. These tests often evaluate a person's DNA to determine ancestry, inherited traits, genetic predispositions to particular diseases, and, in some cases, treatment reactions. Companies that provide DTC genetic testing typically deliver a kit to the consumer, who then collects a DNA sample (usually saliva) and returns it to the company for analysis. Results are often made available online or via a mobile app and are frequently accompanied by interpretations and recommendations.

DTC genetic testing has grown in popularity due to its simplicity and the possible insights it provides about personal health and heritage. Consumers are curious about their genetic predispositions to diseases such as Alzheimer's, cancer, and heart disease, which could influence lifestyle choices or encourage proactive healthcare decisions. Another popular application is ancestry testing, which allows people to learn more about their genetic heritage and connect with distant relatives.

Technological advancements, such as the lower cost of whole genome sequencing, may improve the accuracy and range of information offered by these tests. Integration with electronic health records and medical practitioners may improve the interpretation and use of genetic data in clinical settings. However, worries persist about the accuracy of interpretations, the privacy of genetic data, and the potential psychological consequences of getting sensitive health information directly. Regulation and monitoring of DTC genetic testing will most likely evolve to meet these concerns while maintaining consumer access to useful genetic insights.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

How Increasing Consumer Awareness Driving the Direct-To-Consumer (DTC) Genetic Testing Market?

Increasing consumer knowledge is a major driver of the Direct-to-Consumer (DTC) genetic testing market. Demand for genetic testing services is expected to increase as more individuals become aware of its potential benefits for understanding their health risks, optimizing medical treatments, and making educated lifestyle choices. Awareness campaigns, educational initiatives, and media coverage are critical in alerting the public about the availability, price, and accessibility of direct-to-consumer DNA testing (DTC). This increased awareness not only broadens the market by hiring new customers but also motivates current users to investigate other genetic insights, such as ancestry and tailored wellness programs, thus boosting market growth.

According to the National Library of Medicine, Direct-to-consumer (DTC) genetic tests are sold directly to consumers, without the involvement of a healthcare professional, usually through the Internet. The tests have garnered both favorable and negative attention. In 2008, Time Magazine dubbed 23andMe's DTC whole genome scan the 'Innovation of the Year.' DTC genetic testing websites frequently link to scientific studies and may include interactive features like user forums. In 2012, the typical cost for the testing was several hundred dollars. In 2011, 23andMe reported that the company had sold 100,000 full genome scans.

Increasing Personalized Healthcare and Wellness Trends, the need for DTC genetic testing is expanding as the focus shifts to personalized healthcare and wellness. Consumers are becoming increasingly interested in understanding their genetic makeup to make more informed lifestyle, disease preventive, and treatment decisions. Individuals benefit from DTC genetic testing because it provides significant information about their unique genetic profile, allowing them to take a more personalized approach to their health.

Will Regulatory and Ethical Concerns Impact the Growth of the Direct-to-Consumer (DTC) Genetic Testing Market?

The Direct-to-Consumer (DTC) genetic testing market regulatory and ethical considerations could have a substantial impact on the expansion. Regulatory difficulties, such as different requirements for the accuracy, interpretation, and reporting of genetic test findings, might impede market entry and expansion. Uncertainties about privacy protections and the secure storage of genetic data add to consumer distrust and regulatory concerns.

Ethical difficulties regarding the proper use and interpretation of genetic information, potential psychological effects on consumers, and worries about genetic discrimination all complicate market dynamics. Addressing these concerns through transparent methods, strong data protection measures , and effective regulatory frameworks will be essential for establishing customer trust and guaranteeing long-term success in the DTC genetic testing market.

Sharing DNA poses ethical and privacy concerns. Consumers are concerned about DTC companies gaining illegal access, committing data breaches, or misusing their genetic information, which might impede market growth. Cost and Reimbursement Issues DTC testing is expensive, and insurance coverage may be limited. This can be a barrier to entrance for many prospective clients.

Category-Wise Acumens

Will Heritage and Familial Connections Propel the Ancestry & Relationship Testing Segment for the Direct-to-Consumer (DTC) Genetic Testing Market?

The Direct-to-Consumer (DTC) genetic testing market, the Ancestry & Relationship Testing section is fueled by a strong desire to learn about one's ancestors and family relationships. Ancestry & Relationship Testing dominates the DTC genetic testing market. Many people are very interested in learning about their genetic ancestry, discovering ancestral roots, and connecting with distant relatives. This fascination stems from a combination of personal interest in family history, cultural identification, and the compelling narratives supplied by genealogy. Furthermore, the capacity to find unknown relatives and create family trees using shared genetic data increases the appeal of these services.

The fastest-growing area is expected to be nutrigenomic testing. This part is aimed at a health-conscious audience interested in improving their diet and wellness depending on their genetic composition. As consumers become more aware of the link between genes and diet, they are looking for individualized information to help them improve their health. This area is expected to develop as there is a greater emphasis on preventative measures and a proactive approach to wellbeing.

Will Cost-Effectively Signify the Single Nucleotide Polymorphism (SNP) Chips for the Direct-to-Consumer (DTC) Genetic Testing Market?

In the realm of DTC genetic testing technology, Single Nucleotide Polymorphism (SNP) Chips currently reign supreme. Cost-effectiveness is a key factor driving the use of Single Nucleotide Polymorphism (SNP) chips in the Direct-to-Consumer (DTC) genetic testing market. SNP chips are a very inexpensive means of studying genetic variants across an individual's genome, making them available to a larger user base. These chips allow for the detection of a wide range of genetic markers associated with health, characteristics, and ancestry at a lower cost than whole-genome sequencing. The low cost of SNP chip technology enables DTC genetic testing companies to provide comprehensive genetic insights at a mass market price point, resulting in widespread adoption and market growth.

Whole Genome Sequencing (WGS) may reign supreme in terms of rapid expansion. WGS provides the most thorough analysis by understanding an individual's full genetic code. While more expensive than SNP chips, WGS has enormous potential for future uses. As technology becomes more inexpensive and data interpretation methods improve, WGS is expected to gain popularity. This is owing to its ability to detect a broader spectrum of genetic variants and perhaps provide a more complete picture of a person's health risk.

Country/Region-wise Acumens

Will the High Concentration of Direct-to-Consumer (DTC) Genetic Testing Market Propel the North America?

In the DTC genetic testing market, North America now enjoys a strong position. The high concentration of the Direct-to-Consumer (DTC) genetic testing market is expected to stimulate growth in North America. The region's modern healthcare infrastructure, high consumer awareness, and large disposable income all contribute to a high demand for genetic testing services.

Furthermore, the presence of major direct-to-consumer genetic testing companies, as well as supporting legislative frameworks and substantial technology innovations, contribute to market expansion. North America's leadership in genomics research and innovation is also critical to driving the adoption and development of direct-to-consumer genetic testing, making it a vital market for growth in this sector.

A big population with disposable income is interested in personalized medicine. Furthermore, North America has a strong culture of preventative healthcare and genetic awareness, which drives market growth.

Will Increasing Internet Penetration Lead the Asian Pacific to the Direct-to-Consumer (DTC) Genetic Testing Market?

The baton of quickest growth is going to be passed to the Asia Pacific region. The growing internet penetration is an essential component of the Direct-to-Consumer (DTC) genetic testing market in Asia-Pacific. As internet availability expands, particularly in emerging nations, more people will be able to research and purchase DTC genetic testing services online. The simplicity of accessing information, ordering tests, and receiving results via digital platforms makes genetic testing more accessible to a greater audience.

This region is experiencing a convergence of forces fueling market expansion. Rising disposable income, increased internet penetration, and increased health and wellness consciousness are creating a fertile field for direct-to-consumer genetic testing. Furthermore, numerous Asian countries have large, young populations who are particularly open to innovative technologies and individualized healthcare techniques. This, combined with a fast-rising healthcare infrastructure, is projected to propel the business forward in this region.

Competitive Landscape

The Direct-To-Consumer (DTC) Genetic Testing Market is a dynamic and competitive space, characterized by a diverse range of players vying for market share. These players are on the run for solidifying their presence through the adoption of strategic plans such as collaborations, mergers, acquisitions, and political support.

The organizations are focusing on innovating their product line to serve the vast population in diverse regions. Some of the prominent players operating in the Direct-To-Consumer (DTC) Genetic Testing Market include:

• EasyDNA
• Ancestry

23andMe, Inc.

• Color Health, Inc.
• Genesis HealthCare
• Full Genomes Corporation, Inc.
• Helix OpCo LLC
• Living DNA Ltd
• Mapmygenome
• GenomeWeb
• Gene by Gene, Ltd.
• MyHeritage Ltd.

10x Genomics

• Dante Labs, Inc.

24Genetics

• Laboratory Corporation of America Holdings
• Myriad Genetics, Inc.
• Quest Diagnostics Incorporated
• Uniogen Oy

Latest Developments

• In April 2023, Genesis Healthcare Co.'s GeneLife brand launched Haplo 3.0 in Japan, marking a significant advance to its ancestry services.
• In July 2023, Quest Diagnostics debuted its first DTC-GT, Genetic Insights. The test analyzes a saliva sample to determine the risk of up to 24 genetically inheritable diseases, including colon and breast cancer, blood and heart issues, cystic fibrosis carrier status, sickle cell anemia, and Tay-Sachs disease.
• In January 2022, 23andMe Holding Co., a prominent consumer genetics and research firm, was granted FDA approval for a genetic health risk report on a hereditary prostate cancer marker.

TABLE OF CONTENTS

1. Introduction

• Market Definition
• Market Segmentation
• Research Methodology

2. Executive Summary

• Key Findings
• Market Overview
• Market Highlights

3. Market Overview

• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter's Five Forces Analysis

4. Direct-To-Consumer (DTC) Genetic Testing Market, By Test Type

• Carrier Testing
• Predictive Testing
• Ancestry & Relationship Testing
• Nutrigenomic Testing

5. Direct-To-Consumer (DTC) Genetic Testing Market, By Technology

• Targeted Analysis
• Single Nucleotide Polymorphism (SNP) Chips
• Whole Genome Sequencing (WGS)

6. Regional Analysis

• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

7. Market Dynamics

• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market

8. Competitive Landscape

• Key Players
• Market Share Analysis

9. Company Profiles

• 23andMe
• Ancestry
• Color Genomics
• Helix
• Living DNA
• EasyDNA
• Full Genome Corporation
• Genesis Healthcare
• Family Tree DNA (Gene By Gene)
• MyHeritage

10. Market Outlook and Opportunities

• Emerging Technologies
• Future Market Trends
• Investment Opportunities

11. Appendix

• List of Abbreviations
• Sources and References